Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07182981

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Investigating the Relationship Between the Biopsychosocial Status of Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Not accepted

Summary

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance. Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire application for child and adult scleroderma patientsScales will be applied to cases diagnosed with scleroderma

Timeline

Start date
2025-08-04
Primary completion
2027-08-01
Completion
2027-08-04
First posted
2025-09-19
Last updated
2025-09-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07182981. Inclusion in this directory is not an endorsement.